EUVIMEDEUVIMED entdecken
Äquivalenzstudie

Efficacy and Safety of a Proposed Hyaluronic Acid (Lunaphil Ultra) Compared to the Reference Product (Juvéderm Ultra 4) for the Management of Moderate or Severe Nasolabial Folds: A Randomized, Double-Masked, Within-Subject, Equivalency-Controlled Trial

Kamran Jazayeri iD, Omid Zargari, Hoshyar Gholami, Araz Sabzvari, Hamidreza Kafi, Kamran Balighi

Aesthetic Surgery Journal · 2025

DOI: 10.1093/asj/sjaf156 ↗

Kurz gefasst

Äquivalenzstudie in der Zeitschrift Aesthetic Surgery Journal, 2025. Verfasst von Kamran Jazayeri und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Cosmetic Techniques, Dermal Fillers, Hyaluronic Acid, Nasolabial Fold. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Espad Pharmed Darou Compan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nasolabial folds (NLFs) are a natural alteration that become more noticeable with aging and dramatically affect facial skin beauty. Hyaluronic acid (HA) dermal fillers are frequently utilized to correct these visible signs of aging.

Objective

The objective of this study was to evaluate and compare the effectiveness and safety of Lunaphil Ultra vs Juvéderm Ultra 4 in the treatment of NLFs.

Methods

Each participant received Lunaphil Ultra and Juvéderm Ultra 4 in 1 of their NLFs. For each participant the products were injected at the first visit, and if needed an additional injection (touch-up) was done at the second visit. The duration of the study was 24 weeks for each participant. The primary outcome of this study was to assess the mean level of NLF severity score improvement compared to baseline with the Wrinkle Severity Rating Scale (WSRS) at Week 24.

Results

The mean ± SD level of improvement by WSRS was −0.80 ± 0.66 for Lunaphil Ultra and −0.81 ± 0.67 for the Juvéderm Ultra 4 group (P value > .99). The difference between the 2 groups was within the predefined equivalency margin of ± 0.17. Of the treated NLFs, 71.15% in the Lunaphil Ultra group and 66.35% in the Juvéderm Ultra 4 group received a touch-up injection (P value = .33).

Conclusions

As indicated by the study results, Lunaphil Ultra had an acceptable efficacy and safety profile in the Iranian population and was equivalent to Juvéderm Ultra 4 in WSRS improvement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cosmetic TechniquesDermal FillersHyaluronic AcidNasolabial FoldSkin AgingAdultFemaleHumansMaleMiddle AgedDouble-Blind MethodSeverity of Illness IndexTreatment Outcome

Substanzen

Dermal FillersHyaluronic AcidJuvederm Ultra

Autor:innen und Institutionen

ORCID-Profile: Kamran Jazayeri

Förderung

  • Espad Pharmed Darou Compan

Zitieren

APA

Jazayeri, K., Zargari, O., Gholami, H., Sabzvari, A., Kafi, H., & Balighi, K. (2025). Efficacy and Safety of a Proposed Hyaluronic Acid (Lunaphil Ultra) Compared to the Reference Product (Juvéderm Ultra 4) for the Management of Moderate or Severe Nasolabial Folds: A Randomized, Double-Masked, Within-Subject, Equivalency-Controlled Trial. Aesthetic Surgery Journal. https://doi.org/10.1093/asj/sjaf156

Vancouver

Jazayeri K, Zargari O, Gholami H, Sabzvari A, Kafi H, Balighi K. Efficacy and Safety of a Proposed Hyaluronic Acid (Lunaphil Ultra) Compared to the Reference Product (Juvéderm Ultra 4) for the Management of Moderate or Severe Nasolabial Folds: A Randomized, Double-Masked, Within-Subject, Equivalency-Controlled Trial. Aesthetic Surgery Journal. 2025. doi:10.1093/asj/sjaf156

BibTeX
@article{Jazayeri2025,
  author = {Jazayeri, Kamran and Zargari, Omid and Gholami, Hoshyar and Sabzvari, Araz and Kafi, Hamidreza and Balighi, Kamran},
  title = {Efficacy and Safety of a Proposed Hyaluronic Acid (Lunaphil Ultra) Compared to the Reference Product (Juvéderm Ultra 4) for the Management of Moderate or Severe Nasolabial Folds: A Randomized, Double-Masked, Within-Subject, Equivalency-Controlled Trial},
  journal = {Aesthetic Surgery Journal},
  year = {2025},
  doi = {10.1093/asj/sjaf156}
}
Kostenlos starten →